Biomarkers for ovarian cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 17, 2012
Grant Date -
Jul 2, 2009
app pub date -
Mar 27, 2008
filing date -
Mar 27, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, it has been found that the biomarkers set forth in Table 1 are biomarkers for ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully